SPOTLIGHT -
Ms Kuntz is the assistant managing editor of Psychiatric Times.
Daridorexant: Improvement on Measures of Sleep Onset and Sleep Maintenance
The US Food and Drug Administration has approved a new medication for the treatment of insomnia.
First Colombian With Nonterminal Illness Legally Dies via Euthanasia
In the face of opposition from doctors, clinics, and courts, Victor Escobar became the first Colombian to die via euthanasia on Friday January 7, 2022.
New Northwestern Student Studio Lab Focuses on Mental Health Portrayals in Media
The new Studio Lab at Northwestern University School of Communication aims to fight stigma by providing positive depictions of mental health in media.
Pennsylvania Legislators Push to Increase Awareness of Eating Disorders in Children
Representative Jason Ortitay and Senator Steve Santarsiero have introduced legislation to help increase awareness of eating disorders in children.
“A Viable Option” for Treating Schizophrenia Receives FDA Approval
The supplemental new drug application of brexpiprazole for the treatment of schizophrenia in pediatric patients aged 13 to 17 received FDA approval.
“Helps You Smoke Less”: First Combusted Cigarettes Authorized as Modified Risk Tobacco Products
The FDA authorized the marketing of these tobacco products that help reduce exposure to and consumption of nicotine for smokers.
Exploring the Link Between Migraine and PTSD
Are common genes and signaling pathways involved in PTSD and migraine?
APA, AMA, and Others Go To Bat for Vaccination Requirements
Leading medical organizations support policies requiring COVID-19 vaccination.
Zuranolone: New Data Presented at American College of Neuropsychopharmacology Congress
Data from a clinical program evaluating the efficacy and safety of zuranolone was presented at the American College of Neuropsychopharmacology Congress. What new developments did they share?
Conference Presents Clinical Reviews and Updates
Psychiatric Times, your go-to source for what is relevant and important in the field, is pleased to share the following highlights from the 2021 Neuroscience Education Institute Congress.
ADHD and Generalized Anxiety Disorder: Hand in Hand?
Individuals with ADHD are 4 times more likely to have generalized anxiety disorder at some point in their life.
Breaking the Trend: New CDC Data on Suicide
The Chief Medical Officer for the American Foundation for Suicide Prevention sat down to talk with Psychiatric Times about the new data on suicide deaths between 2019 and 2020.
Bigger Than Just 1 Person: Care for Transgender Individuals in Prison
Two transgender women in North Carolina are facing struggles in getting prisons to acknowledge their gender identity. What does this say about care for incarcerated transgender individuals in general?
Pimavanserin: New Positive Study Results
Negative symptoms of schizophrenia are associated with higher overall morbidity and decreased functioning. These study results offer hope.
Stopping the Opioid Crisis: Evidence-Based Public Health Approaches
A coalition of 240 organizations came together to urge Congress to pass legislation to fight the opioid crisis.
Aducanumab: A Tentative Position
The American Academy of Neurology issued a position statement for mental health professionals, warning them to carefully discuss the benefits and known harms of aducanumab.
No-Skip November: Don’t Miss These Articles
Cranberry sauce and clinical pearls: the most delicious of combos. Check out more of our November issue.
Bipolar Disorder: The Difficult Diagnosis
Need a recap of the custom Around the Practice video program on bipolar disorder? We've got you covered.
Children with ADHD and Reward-Related Dysfunctions: The Impact of Oppositional and Callous-Unemotional Symptoms
A new study examined the relationship between ADHD and oppositional defiant and conduct disorder, callous-unemotional traits, and reward-related inhibitory control.
No "Cookie Cutter" Patients: Managing Treatment-Resistant Depression
Treatment-resistant depression: how to diagnose, what treatment options are available, and how to best help patients.
New Treatment Option for ADHD: Unique Pharmacokinetic Profile and Range of Dosing Options
The FDA has approved Dyanavel XR, extended release once-daily tablets for the treatment of attention-deficit/hyperactivity disorder.
Infusing Lived Experiences for Trans and Gender Diverse Patients
How can you provide affirmative mental health care for transgender and gender diverse patients?
The Love-Hate Relationship with Benzodiazepines
Benzodiazepines: a class of medications that evokes that a visceral reaction.
From Day 1: ADHD and Comorbid Conditions
Here’s how to integrate treatment strategies that address both ADHD and comorbid conditions.
Celebrating Psychiatry: Conference Highlights Advances
Did you miss the Annual Psychiatric Times World CME Conference? Don't worry, we've got you covered.
Mindfulness for Pediatric ADHD
Can mindfulness be an additional therapy to help treat ADHD in children?
Child and Adolescent Mental Health: A National Emergency
Three leading groups in child and adolescent mental health have declared a state of emergency for the nation’s youth.
“Never Silence Your Pain”: Life After a Suicide Attempt
One man shares his suicide survival story, and what he does to aid suicide prevention.
A Life and Death Measure: Eating Disorder Treatment
Nearly 80% of eating disorders go undetected. What screening tools can help identify them?
New Investigational Social Anxiety Disorder Drug Differentiates Mechanism of Action
PH94B for the treatment of social anxiety disorder further differentiates its mechanism of action from benzodiazepines in a new lab rat preclinical study.